BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27051247)

  • 1. Naturalistic Pharmacotherapy Compliance among Pediatric Patients with Attention Deficit/Hyperactivity Disorder: a Study Based on Three-Year Nationwide Data.
    Hong M; Kim B; Hwang JW; Bhang SY; Choi HY; Oh IH; Lee YJ; Bahn GH
    J Korean Med Sci; 2016 Apr; 31(4):611-6. PubMed ID: 27051247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nationwide rate of attention-deficit hyperactivity disorder diagnosis and pharmacotherapy in Korea in 2008-2011.
    Hong M; Kwack YS; Joung YS; Lee SI; Kim B; Sohn SH; Chung US; Yang J; Bhang SY; Hwang JW; Choi HY; Oh IH; Lee YJ; Bahn GH
    Asia Pac Psychiatry; 2014 Dec; 6(4):379-85. PubMed ID: 25277653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
    Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
    J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 36 month naturalistic retrospective study of clinic-treated youth with attention-deficit/hyperactivity disorder.
    Hong M; Lee WH; Moon DS; Lee SM; Chung US; Bahn GH
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):341-6. PubMed ID: 24955936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan.
    Wang LJ; Yang KC; Lee SY; Yang CJ; Huang TS; Lee TL; Yuan SS; Shyu YC
    PLoS One; 2016; 11(8):e0161061. PubMed ID: 27518196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
    Song I; Lee MS; Lee EK; Shin JY
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 28631372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in Germany.
    Braun S; Russo L; Zeidler J; Linder R; Hodgkins P
    Clin Ther; 2013 May; 35(5):673-85. PubMed ID: 23587606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of negative media publicity on attention-deficit/hyperactivity disorder medication in Taiwan.
    Wang LJ; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Shyu YC
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):45-53. PubMed ID: 26549311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC; Khoza S; Oladapo A
    Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder.
    Perwien A; Hall J; Swensen A; Swindle R
    J Manag Care Pharm; 2004; 10(2):122-9. PubMed ID: 15032561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan.
    Wang LJ; Shyu YC; Yuan SS; Yang CJ; Yang KC; Lee TL; Lee SY
    J Psychiatr Res; 2016 Jan; 72():6-14. PubMed ID: 26519764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program.
    Lawson KA; Johnsrud M; Hodgkins P; Sasané R; Crismon ML
    Clin Ther; 2012 Apr; 34(4):944-956.e4. PubMed ID: 22444786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influential factors for methylphenidate treatment compliance in children with attention deficit hyperactivity disorder].
    Ding KJ; Liu YF; Kang CY; Liu RX; Li XR; Wan S
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 May; 15(5):343-7. PubMed ID: 23676934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study.
    Mikolajczyk R; Horn J; Schmedt N; Langner I; Lindemann C; Garbe E
    JAMA Pediatr; 2015 Apr; 169(4):391-5. PubMed ID: 25686215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.
    Lindemann C; Langner I; Kraut AA; Banaschewski T; Schad-Hansjosten T; Petermann U; Petermann F; Schreyer-Mehlhop I; Garbe E; Mikolajczyk RT
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):307-14. PubMed ID: 22856384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study.
    Shin JY; Roughead EE; Park BJ; Pratt NL
    BMJ; 2016 May; 353():i2550. PubMed ID: 27245699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An observational study of pharmacological treatment in primary care of children with ADHD in the United kingdom.
    Raman SR; Marshall SW; Gaynes BN; Haynes K; Naftel AJ; Stürmer T
    Psychiatr Serv; 2015 Jun; 66(6):617-24. PubMed ID: 25726974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
    Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
    Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.